133 related articles for article (PubMed ID: 7538851)
1. Enhancement of neutrophil function by in vivo filgrastim treatment for prophylaxis of sepsis in surgical intensive care patients.
Weiss M; Gross-Weege W; Schneider M; Neidhardt H; Liebert S; Mirow N; Wernet P
J Crit Care; 1995 Mar; 10(1):21-6. PubMed ID: 7538851
[TBL] [Abstract][Full Text] [Related]
2. Effects of exogenous recombinant human granulocyte colony-stimulating factor (filgrastim, rhG-CSF) on neutrophils of critically ill patients with systemic inflammatory response syndrome depend on endogenous G-CSF plasma concentrations on admission.
Weiss M; Voglic S; Harms-Schirra B; Lorenz I; Lasch B; Dumon K; Gross-Weege W; Schneider EM
Intensive Care Med; 2003 Jun; 29(6):904-914. PubMed ID: 12682721
[TBL] [Abstract][Full Text] [Related]
3. Increased respiratory burst activity of neutrophils in patients with aplastic anemia: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.
Ohsaka A; Kitagawa S; Yuo A; Motoyoshi K; Ohta M; Miura Y; Takaku F; Saito M
Exp Hematol; 1992 Oct; 20(9):1090-3. PubMed ID: 1281785
[TBL] [Abstract][Full Text] [Related]
4. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on respiratory burst activity of neutrophils in patients with myelodysplastic syndromes.
Ohsaka A; Kitagawa S; Yuo A; Motoyoshi K; Furusawa S; Miura Y; Takaku F; Saito M
Clin Exp Immunol; 1993 Feb; 91(2):308-13. PubMed ID: 7679062
[TBL] [Abstract][Full Text] [Related]
5. Human recombinant GM-CSF selectively primes receptor mediated respiratory burst of neutrophils in vitro.
Leino L; Nuutila J; Pelliniemi TT; Rajamäki A
Immunol Lett; 1993 Sep; 38(1):26-31. PubMed ID: 8300150
[TBL] [Abstract][Full Text] [Related]
6. Effect of preoperative prophylaxis with filgrastim in cancer neck dissection.
Wenisch C; Werkgartner T; Sailer H; Patruta S; Krause R; Daxboeck F; Parschalk B
Eur J Clin Invest; 2000 May; 30(5):460-6. PubMed ID: 10809907
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the potency of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factors in neutropenic and nonneutropenic CD rats.
Nohynek GJ; Plard JP; Wells MY; Zerial A; Roquet F
Cancer Chemother Pharmacol; 1997; 39(3):259-66. PubMed ID: 8996530
[TBL] [Abstract][Full Text] [Related]
8. Actin polymerization in neutrophils from donors of peripheral blood stem cells: divergent effects of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor.
Carulli G; Mattii L; Azzarà A; Brizzi S; Galimberti S; Zucca A; Benedetti E; Petrini M
Am J Hematol; 2006 May; 81(5):318-23. PubMed ID: 16628714
[TBL] [Abstract][Full Text] [Related]
9. In vivo activation of human neutrophil functions by administration of recombinant human granulocyte colony-stimulating factor in patients with malignant lymphoma.
Ohsaka A; Kitagawa S; Sakamoto S; Miura Y; Takanashi N; Takaku F; Saito M
Blood; 1989 Dec; 74(8):2743-8. PubMed ID: 2479431
[TBL] [Abstract][Full Text] [Related]
10. The effect of recombinant human granulocyte/macrophage-colony-stimulating factor (rHu GM-CSF) and rHu G-CSF administration on neutrophil chemiluminescence assay in patients following cyclic chemotherapy.
Aslan M; Yucel G; Bozcuk H; Savas B
Cancer Immunol Immunother; 1998 Nov; 47(3):176-81. PubMed ID: 9829843
[TBL] [Abstract][Full Text] [Related]
11. Filgrastim (RHG-CSF) related modulation of the inflammatory response in patients at risk of sepsis or with sepsis.
Weiss M; Gross-Weege W; Harms B; Schneider EM
Cytokine; 1996 Mar; 8(3):260-5. PubMed ID: 8833041
[TBL] [Abstract][Full Text] [Related]
12. Administration of recombinant human granulocyte-colony stimulating factor to septic neonates induces neutrophilia and enhances the neutrophil respiratory burst and beta2 integrin expression. Results of a randomized controlled trial.
Drossou-Agakidou V; Kanakoudi-Tsakalidou F; Sarafidis K; Taparkou A; Tzimouli V; Tsandali H; Kremenopoulos G
Eur J Pediatr; 1998 Jul; 157(7):583-8. PubMed ID: 9686822
[TBL] [Abstract][Full Text] [Related]
13. Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia.
Kocherlakota P; La Gamma EF
Pediatrics; 1998 Nov; 102(5):1107-11. PubMed ID: 9794941
[TBL] [Abstract][Full Text] [Related]
14. Effect of recombinant human granulocyte colony-stimulating factor on human neutrophil adherence in vitro.
Okada Y; Kawagishi M; Kusaka M
Experientia; 1990 Oct; 46(10):1050-3. PubMed ID: 1699783
[TBL] [Abstract][Full Text] [Related]
15. In vivo administration of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor increases neutrophil oxidative burst activity.
Wiltschke C; Krainer M; Nanut M; Wagner A; Linkesch W; Zielinski CC
J Interferon Cytokine Res; 1995 Mar; 15(3):249-53. PubMed ID: 7584671
[TBL] [Abstract][Full Text] [Related]
16. fMLP-induced CD11b/CD18 upregulation on neutrophils from patients with non-Hodgkin's lymphomas treated with recombinant human granulocyte colony-stimulating factor.
Carulli G; Azzarà A; Minnucci S; Angiolini C; Sbrana S; Ambrogi F
J Exp Clin Cancer Res; 1997 Sep; 16(3):301-8. PubMed ID: 9387905
[TBL] [Abstract][Full Text] [Related]
17. Perioperative treatment with filgrastim stimulates granulocyte function and reduces infectious complications after esophagectomy.
Schäfer H; Hübel K; Bohlen H; Mansmann G; Hegener K; Richarz B; Oberhäuser F; Wassmer G; Hölscher AH; Pichlmaier H; Diehl V; Engert A
Ann Hematol; 2000 Mar; 79(3):143-51. PubMed ID: 10803937
[TBL] [Abstract][Full Text] [Related]
18. Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial.
Maher DW; Lieschke GJ; Green M; Bishop J; Stuart-Harris R; Wolf M; Sheridan WP; Kefford RF; Cebon J; Olver I; McKendrick J; Toner G; Bradstock K; Lieschke M; Cruickshank S; Tomita DK; Hoffman EW; Fox RM; Morstyn G
Ann Intern Med; 1994 Oct; 121(7):492-501. PubMed ID: 7520676
[TBL] [Abstract][Full Text] [Related]
19. Safety of a low-dosage Filgrastim (rhG-CSF) treatment in non-neutropenic surgical intensive care patients with an inflammatory process.
Gross-Weege W; Weiss M; Schneider M; Wenning M; Harms B; Dumon K; Ohmann C; Röher HD
Intensive Care Med; 1997 Jan; 23(1):16-22. PubMed ID: 9037635
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
